{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:16:49Z","timestamp":1789031809912,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T00:00:00Z","timestamp":1367452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002195","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T04:16:41Z","timestamp":1367554601000},"page":"e2195","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":147,"title":["Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison"],"prefix":"10.1371","volume":"7","author":[{"given":"Gl\u00e1ucia F.","family":"Cota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos R.","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiani Oliveira","family":"Fereguetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,2]]},"reference":[{"issue":"(2)","key":"ref1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"J Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"(9)","key":"ref2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2217\/fmb.10.92","article-title":"Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India","volume":"5","author":"HW Murray","year":"2010","journal-title":"Future Microbiol"},{"issue":"(6)","key":"ref3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4269\/ajtmh.2004.71.787","article-title":"Treatment of visceral leishmaniasis in 2004","volume":"71","author":"HW Murray","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"(1)","key":"ref4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0022-3859.929","article-title":"Leishmaniasis in HIV infection","volume":"49","author":"R Paredes","year":"2003","journal-title":"J Postgrad Med"},{"issue":"(6)","key":"ref5","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"GF Cota","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"(6)","key":"ref6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"K Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"(6)","key":"ref7","first-page":"22","article-title":"Leishmaniasis in HIV-infected persons: a review","volume":"3","author":"R Paredes","year":"1997","journal-title":"J Int Assoc Physicians AIDS Care"},{"issue":"(2)","key":"ref8","first-page":"151","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"EM Moore","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"(26)","key":"ref9","first-page":"1","article-title":"Indirect comparisons of competing interventions","volume":"9","author":"AM Glenny","year":"2005","journal-title":"Health Technol Assess"},{"issue":"(2)","key":"ref10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S0266462308080240","article-title":"Direct versus indirect comparisons: a summary of the evidence","volume":"24","author":"G Gartlehner","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"issue":"(7)","key":"ref11","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"ref12","unstructured":"Higgins JPT, Green S (2011). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cochrane-handbook.org\" xlink:type=\"simple\">www.cochrane-handbook.org<\/ext-link>. Accessed 2 September 2012."},{"key":"ref13","unstructured":"Wells GA, Shea B, O&apos;Connell D, Peterson J, Welch V, et al.. (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\" xlink:type=\"simple\">www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp<\/ext-link>. Accessed 25 November 2012."},{"issue":"(11)","key":"ref14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"JA Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"(2)","key":"ref15","first-page":"73","article-title":"Visceral leishmaniasis in patients with HIV infection","volume":"13","author":"E Ribera","year":"1995","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"(5)","key":"ref16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9343(97)89503-4","article-title":"Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"100","author":"E Ribera","year":"1996","journal-title":"Am J Med"},{"issue":"(12)","key":"ref17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF01700556","article-title":"Visceral leishmaniasis in patients infected with the human immunodeficiency virus","volume":"16","author":"F Laguna","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"(3)","key":"ref18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0163-4453(90)93933-J","article-title":"Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS","volume":"21","author":"C Montalban","year":"1990","journal-title":"J Infect"},{"issue":"(2)","key":"ref19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-4453(96)91343-2","article-title":"Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome)","volume":"32","author":"R Russo","year":"1996","journal-title":"The Journal of infection"},{"issue":"(3)","key":"ref20","first-page":"130","article-title":"Serologic cross-reactions to <italic>Leishmania infantum<\/italic> using indirect immunofluorescence in HIV+ and HIV- patients with active tuberculosis","volume":"6","author":"R Lopez-Velez","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"(14)","key":"ref21","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","article-title":"HIV viral load and response to antileishmanial chemotherapy in co-infected patients","volume":"13","author":"N Berhe","year":"1999","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1179\/000349803225002606","article-title":"Treatment of leishmaniasis in HIV-positive patients","volume":"97","author":"F Laguna","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"(3)","key":"ref23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"K Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"(4)","key":"ref24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkm294","article-title":"Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients","volume":"60","author":"I Molina","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"(7)","key":"ref25","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/cid\/cir521","article-title":"Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India","volume":"53","author":"PK Sinha","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"(12)","key":"ref26","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence","volume":"53","author":"K Ritmeijer","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"(9)","key":"ref27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group","volume":"13","author":"F Laguna","year":"1999","journal-title":"AIDS"},{"issue":"(5)","key":"ref28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.1999.61.766","article-title":"High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients","volume":"61","author":"J Delgado","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"(10)","key":"ref29","first-page":"506","article-title":"The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection","volume":"14","author":"FM Delgado","year":"1997","journal-title":"Ann Med Interne"},{"issue":"(2)","key":"ref30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0035-9203(95)90476-X","article-title":"Visceral leishmaniasis and HIV-1 co-infection in southern France","volume":"89","author":"E Rosenthal","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"(1)","key":"ref31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study","volume":"80","author":"V Pintado","year":"2001","journal-title":"Medicine"},{"issue":"(6)","key":"ref32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1198-743x.2001.00262.x","article-title":"HIV-associated visceral leishmaniasis","volume":"7","author":"V Pintado","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"(2)","key":"ref33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/14787210.4.2.187","article-title":"Treatment options for visceral leishmaniasis","volume":"4","author":"M den Boer","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"(7)","key":"ref34","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"F Frezard","year":"2009","journal-title":"Molecules"},{"issue":"(4)","key":"ref35","first-page":"319","article-title":"Curr Pharm Des","volume":"8","author":"SL Croft","year":"2002","journal-title":"Curr Pharm Des"},{"key":"ref36","unstructured":"Bern C (2012) Treatment of visceral leishmaniasis. UpToDate, Inc. Wolters Kluwer Health. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.uptodate.com\/contents\/treatment-of-visceral-leishmaniasis\" xlink:type=\"simple\">http:\/\/www.uptodate.com\/contents\/treatment-of-visceral-leishmaniasis<\/ext-link>. Accessed 2 November 2012."},{"issue":"(3)","key":"ref37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"BL Herwaldt","year":"1992","journal-title":"The Am J Trop Med Hyg"},{"issue":"(1)","key":"ref38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","article-title":"AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience","volume":"49","author":"J Adler-Moore","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"(4)","key":"ref39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"M Balasegaram","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"issue":"(11)","key":"ref40","doi-asserted-by":"crossref","first-page":"e11054","DOI":"10.1371\/journal.pone.0011054","article-title":"Indirect comparisons: a review of reporting and methodological quality","volume":"5","author":"S Donegan","year":"2010","journal-title":"PloS One"},{"issue":"(7387)","key":"ref41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"F Song","year":"2003","journal-title":"BMJ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"d4909","DOI":"10.1136\/bmj.d4909","article-title":"Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study","volume":"343","author":"F Song","year":"2011","journal-title":"BMJ"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:25:31Z","timestamp":1588987531000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002195"}},"subtitle":[],"editor":[{"given":"Richard","family":"Reithinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,2]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002195","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,2]]}}}